Nabriva gets first approval in novel antibiotic class

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 19, 2019 at 11:52 PM.

  1. #1 cafead, Aug 19, 2019 at 11:52 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,956
    Likes Received:
    3
    via Nabriva plans to launch its first approved antibiotic, Xenleta lefamulin, in mid-September to treat community-acquired bacterial pneumonia, and the company has taken steps to facilitate Xenleta's adoption through negotiations with healthcare providers, payers and pharmacies.

    article source
     
    Quote

Reply to Thread